Doris Matsui (D-CA)

340B PATIENTS Act of 2025

H.R. 4581 · House bill Health

A Democratic bill with 21 Democratic cosponsors · See all 21 cosponsors

Last activity — Referred to the House Committee on Energy and Commerce.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, known as the "340B PATIENTS Act of 2025," aims to protect the accessibility of drugs through the 340B drug discount program. It seeks to clarify that drug manufacturers must offer discounted pricing regardless of how or where a drug is dispensed. The Act prevents manufacturers from placing certain conditions on covered entities that might limit drug delivery, purchase mechanisms, or locations. It specifically addresses contract pharmacy relationships used by hospitals, clinics, and health centers. Additionally, the bill establishes civil monetary penalties for manufacturers that intentionally violate these requirements.

Yes· 3 of 10

  • Scored +7

    Does this make health care easier to get in general?

    The bill ensures patients can access vital specialty drugs by preventing manufacturers from placing restrictive conditions on dispensing locations.

  • Scored +6

    Does this lower the price of prescription medicines?

    The bill ensures drug manufacturers provide discounted prices regardless of how or where drugs are dispensed via contract pharmacies.

  • Scored +5

    Would households on low incomes be better off under this?

    The bill helps hospitals and clinics stretch resources to provide more comprehensive care to those in need through the 340B program.

The opposite

No question was scored the opposite.